Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Beard

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Antiviral Therapy|November 13, 2004
Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studiesMichael R Beard
Methods in Molecular Medicine|February 6, 2004
Monitoring gene expression using DNA microarrays during hepatitis B virus infectionMichael R Beard, Stephen Locarnini
Biomarkers in Medicine|March 28, 2012
The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatmentKarla J Helbig, Michael R Beard
Gastroenterology|September 30, 2014
HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral actionNicholas S Eyre, Michael R Beard
Hepatology (Baltimore, Md.)|June 29, 2007
Claudin-1, a new junction in the hepatitis C virus entry pathwayMichael R Beard, Fiona J Warner
Journal of Molecular Biology|October 26, 2013
The role of viperin in the innate antiviral responseKarla J Helbig, Michael R Beard
Hepatology (Baltimore, Md.)|February 28, 2008
Control of HCV replication: when size does not matterMichael R Beard, Karla J Helbig
World Journal of Gastroenterology|March 19, 2010
Impact of alcohol on hepatitis C virus replication and interferon signalingErin M McCartney, Michael R Beard
Hepatology (Baltimore, Md.)|May 1, 2010
Hepatitis C virus infection in living colorNicholas S Eyre, Michael R Beard
Antiviral Therapy|November 29, 2012
Antiviral resistance and direct-acting antiviral agents for HCVAmanda L Aloia, Stephen Locarnini, Michael R Beard
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Antiviral Therapy|November 13, 2004
Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studiesMichael R Beard
Methods in Molecular Medicine|February 6, 2004
Monitoring gene expression using DNA microarrays during hepatitis B virus infectionMichael R Beard, Stephen Locarnini
Biomarkers in Medicine|March 28, 2012
The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatmentKarla J Helbig, Michael R Beard
Gastroenterology|September 30, 2014
HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral actionNicholas S Eyre, Michael R Beard
Hepatology (Baltimore, Md.)|June 29, 2007
Claudin-1, a new junction in the hepatitis C virus entry pathwayMichael R Beard, Fiona J Warner
Journal of Molecular Biology|October 26, 2013
The role of viperin in the innate antiviral responseKarla J Helbig, Michael R Beard
Hepatology (Baltimore, Md.)|February 28, 2008
Control of HCV replication: when size does not matterMichael R Beard, Karla J Helbig
World Journal of Gastroenterology|March 19, 2010
Impact of alcohol on hepatitis C virus replication and interferon signalingErin M McCartney, Michael R Beard
Hepatology (Baltimore, Md.)|May 1, 2010
Hepatitis C virus infection in living colorNicholas S Eyre, Michael R Beard
Antiviral Therapy|November 29, 2012
Antiviral resistance and direct-acting antiviral agents for HCVAmanda L Aloia, Stephen Locarnini, Michael R Beard
Pageof 8